WeVote
Log In

Bill

Bill

SB 89

Authorizing the animal health commissioner to adopt rules and regulations to administer the poultry disease control act and to establish an annual participation fee for participation in the national poultry improvement plan, a certification fee for persons performing testing and diagnostic services and a testing fee per visit to each location participating in the plan.

2025-2026 Regular Session

Kansas empowers animal health commissioner to levy participation, certification, and testing fees for poultry disease monitoring under the National Poultry Improvement Plan.

Approved by Governor on Tuesday, April 1, 2025
0
WeVote Research Nonpartisan
Bill Summary · SB 89

Legislative bill overview

SB 89 authorizes Kansas's animal health commissioner to establish rules for administering the Poultry Disease Control Act and to implement three new fees: an annual participation fee for the National Poultry Improvement Plan, a certification fee for testing personnel, and per-visit testing fees for participating locations. The bill received emergency final passage with unanimous support and was signed into law in April 2025.

Why is this important

Poultry disease outbreaks (particularly avian influenza) pose significant economic and public health risks to Kansas's substantial poultry industry. This bill creates a dedicated funding mechanism for disease monitoring and control by shifting costs to participants rather than relying solely on general state funds. The fee structure enables sustained, proactive surveillance that can prevent costly disease spread across commercial and backyard flocks.

Potential points of contention

  • Cost burden on small producers: Participation and testing fees may disproportionately impact small-scale and hobby poultry operations with limited budgets, potentially creating barriers to disease prevention participation
  • Regulatory discretion: The bill grants broad rule-making authority to the commissioner without specifying fee caps or adjustment procedures, raising questions about cost predictability and oversight
  • Fee justification: No transparency requirement is apparent regarding how fees are calculated, what they fund, or how effectiveness is measured against disease outcomes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.